itolizumab   Click here for help

GtoPdb Ligand ID: 9421

Synonyms: Alzumab® | T1h
Approved drug Immunopharmacology Ligand
itolizumab is an approved drug (DCGI (India; 2013))
Compound class: Antibody
Comment: Itolizumab is a first in class humanized IgG1 monoclonal antibody targeting T cell CD6. It is being developed by Biocon Limited for its anti-inflammatory potential in autoimmune conditions.
Click here for help
No information available.
Summary of Clinical Use Click here for help
Itolizumab has been licensed India since 2013 as a treatmant for chronic plaque psoriasis [2-4]. Itolizumab has also been evaluated in patients with rheumatoid arthritis [5].